Grifols Study Suggests Repeated Plasmapheresis May Reduce "Bad" LDL Cholesterol Levels While Increasing "Good" HDL Cholesterol Levels in Some I... (el known as multi-variable regression to...)

HOME >> MEDICINE >> TECHNOLOGY

Grifols Study Suggests Repeated Plasmapheresis May Reduce "Bad" LDL Cholesterol Levels While Increasing "Good" HDL Cholesterol Levels in Some Individuals

Date:3/14/2012

el known as multi-variable regression to analyze the study data, the researchers estimated that plasmapheresis could reduce the levels of low density lipoproteins (LDL) or "bad" cholesterol by more than 30 mg/dL among individuals with high levels (> 160 mg/dL) or higher than desirable levels (>130 mg/dL), when plasmapheresis procedures are performed two to four days apart. This effect was more significant in women, in whom cholesterol could be reduced by up to 35 mg/dL. A similar reduction pattern is estimated to occur in individuals with high total cholesterol levels (>240mg/dL) or higher than desirable levels (>200mg/dL), with the reductions in these cases potentially reaching 45mg/dL and 32 mg/dL, respectively.

The cholesterol-lowering effects of plasmapheresis appeared to last only as long as the procedure continued at regular intervals, with cholesterol levels gradually returning to baseline following long periods without plasmapheresis. The same pattern of reductions could be seen, although to a lesser degree, when subsequent plasmapheresis procedures were performed more than 10 days apart. Among individuals with normal baseline cholesterol levels, the study results suggested that plasmapheresis would not cause significant changes. The study results also suggest that plasmapheresis could increase the levels of high-density lipoproteins (HDL) or "good" cholesterol in individuals who presented low baseline levels of HDL cholesterol.

Study Design
The multi-center longitudinal study was conducted in 9 plasma donor centers in the U.S., with blood analyses performed prior to plasma donations to measure initial levels of total cholesterol, HDL (high density lipoproteins), and LDL (low density lipoproteins). Plasma was collected from first-time donors or from donors who had not donated plasma for at least six months. Participants were closely monitored throughout the process a
'/>"/>

SOURCE Grifols
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Grifols Announces New North American Commercial Operations Organization
2. Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics
3. Grifols Announces the Appointment of Thomas Glanzmann as Chairman of its New Board of Directors for U.S. Operations
4. Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff
5. Grifols Establishes Expert Advisory Council in Transfusion Medicine
6. Grifols Signs Cooperative Agreement for Commercialization of Immunohematology Diagnostic Products in the US
7. Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)
8. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
9. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
10. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
11. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering. In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering. A portion of the proceeds will ...

(Date:5/23/2013)... -- A recently published clinical study conducted at TOPS Comprehensive ... demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary ... The study, "Implementation of Breast Tomosynthesis in a Routine ... Stephen L. Rose , MD, and published ... of Roentgenology (AJR). The AJR is the scientific ...

(Date:5/23/2013)... , May 23, 2013 More than half ... not benefit from chemotherapy and still have excellent outcomes. ... of one of the largest sources of online consumer ... and interactive Facebook page provide recently diagnosed women with ... safely avoid chemotherapy. "We anticipate these innovative ...

Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2 Nephros Announces Completion of Rights Offering 3 Nephros Announces Completion of Rights Offering 4 First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2 First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3

[0] Nephros Announces Completion of Rights Offering [0] First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams [0] Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions

... Mass. , May 5 LightLab Imaging, ... Optical Coherence Tomography (OCT) technology for vascular and other ... and Drug Administration (FDA) for the C7-XR Imaging System ... LightLab,s latest generation Frequency Domain OCT (FD-OCT™) technology, are ...

... May 5 Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH) ... Care Conference in New York, New York , on May 11, 2010 , ... , , A live ... . The webcast will be archived for replay following the conference. , ...

Cached Medicine Technology:LightLab Imaging Announces FDA Clearance of C7-XR(TM) Coronary OCT Products in the United States 2 LightLab Imaging Announces FDA Clearance of C7-XR(TM) Coronary OCT Products in the United States 3 LightLab Imaging Announces FDA Clearance of C7-XR(TM) Coronary OCT Products in the United States 4 Zimmer Holdings to Present at Bank of America Merrill Lynch 2010 Health Care Conference 2

LightLab Imaging Announces FDA Clearance of C7-XR(TM) Coronary OCT Products in the United States Zimmer Holdings to Present at Bank of America Merrill Lynch 2010 Health Care Conference

(Date:5/25/2013)... York (PRWEB) May 25, 2013 ... litigation underway in U.S. District Court, Western District of ... According to a Case Management Order issued on ... the filing of contested motions in the Actos bladder ... motions. (In re: Actos Product Liability Litigation, MDL No. ...

(Date:5/25/2013)... May 25, 2013 Studies from Johns ... are carrying excessive weight and their inability to get ... simply losing weight can naturally relieve many symptoms. ... improvement in sleep quality was significantly associated with overall ... study dated November 6th, 2012, researchers monitored ...

(Date:5/25/2013)... (PRWEB) May 25, 2013 The ... ranging from irritable bowel syndrome (IBS) to bloating, ... among the most long-lasting, embarrassing, frustrating and difficult ... foods for digestive health have provided a ... are many factors contributing to digestive health issues, ...

(Date:5/25/2013)... (PRWEB) May 25, 2013 Dr. Farooq ... surgery clinic in Dubai, has announced his practice’s adoption ... is the only FDA-cleared femtosecond laser proven with more ... safety and precision of LASIK. , “We are happy ... Advanced Femtosecond Laser at our Dubai LASIK practice,” Ashraf ...

(Date:5/25/2013)... Prairie Living at Chautauqua , ... American Red Cross Blood Drive from 1:30 to 5:30 ... is located at 955 Villa Ct. in Carbondale, Illinois, ... Medicaid, who need some help to maintain their independence.. ... Andrea Arview Frey, Director of Marketing for Prairie Living. ...

Breaking Medicine News(10 mins):Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2 Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2 Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2 Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2 Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2

[0] Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep [0] Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org [0] Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method [0] Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive

... New York Health AdvisoryNEW YORK, Feb. 12 Asthma ... in New York City, according to the United States ... suggests that there are many causes for asthma attacks, ... system changes that result from the presence, or lack ...

... Non-attorney Representation Services , ... Belleville, Ill. (PRWEB) February ... can increase their changes of getting awarded when they hire representation, ... the Social Security Disability Insurance (SSDI) process each year. ...

... doctors, nurses, and other medical personnel wear scrubs in the ... and ties to work. What we wear, as we ... comfortable, all the while maintaining our professionalism. With all ... someone go about making an important decision such as which ...

... has been enormous public controversy over the piece published ... stimulus bill. Betsy McCaughey, Ph.D. states:1) While ... Coordinator of Health Information Technology was created by former ... for doctors and hospitals that voluntarily adopted electronic medical ...

... RUTHERFORD, N.J., Feb. 11 Cambrex Corporation (NYSE: CBM ... period ended December 31, 2008., , ... quarter 2007 and full year sales decreased 3.7% excluding the impact ... for the quarter and year, respectively. , ...

... and MTA: CTIC) announced today that the Borsa Italiana, ... Company,s common stock on the MTA stock,market in Milan, ... on February 10th. As a result of the ... additionally been halted on the NASDAQ Stock Market,pursuant to ...

Home Care Tips for Reducing the Risk of Childhood Hospitalizations Due to Asthma Social Security Disability Applicants Increase Chances for Benefits with Representation So Many Nursing Scrubs, So Many Decisions: blue sky scrubs Offers Tips on How to Find That Perfect Set of Medical Scrubs Betsy McCaughey Responds to Poorly Informed Critics Cambrex Reports Fourth Quarter and Full Year 2008 Results Cell Therapeutics Updates Shareholders on Trading

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Pb, Urine Parvovirus B19 Antibody, IgM Parvovirus B19 Antibodies, IgG & IgM Partial Thromboplastin Time with Reflex to PTT 1:1 Mix